Compare iShares Core High Dividend ETF (HDV) vs Ionis Pharmaceuticals Inc. Common Stock (IONS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core High Dividend ETF vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? iShares Core High Dividend ETF trades at $29.8 (market cap $15.36B), while Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.10B). The key difference: iShares Core High Dividend ETF is far larger — about 2.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and iShares Core High Dividend ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core High Dividend ETF for 118 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| HDV | IONS | |
|---|---|---|
Market Cap | $15.36B | $7.10B |
Volume | 3,407,621 | 2,027,457 |
52-Week High | $29.93 | $86.50 |
52-Week Low | $23.64 | $42.38 |
Typical Hold Time | 118 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $6.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HDV (iShares Core High Dividend ETF) trades at $29.15, up 0.28% with a bullish technical signal from moving averages and oscillators. The ETF recently underwent a major sector rebalance, reducing healthcare exposure while increasing energy, staples, and utilities. Current RSI levels suggest mild overbought conditions, with support and resistance clustered around $29.
The outlook remains positive given the ETF's focus on high dividend-paying stocks during a period of market rotation toward income strategies. Key risks include sector concentration with 62% in three sectors and potential yield compression if interest rates continue rising. The 3% yield provides income appeal but requires monitoring of underlying holdings' dividend sustainability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →
